Replicative senescence is thought to be a signi®cant barrier to human tumorigenesis, which in human ®bro-blasts, and many other cell types, can be overcome experimentally by combined loss of function of p53 and Rb`pathways'. To avoid the confounding pleiotropic eects of HPVE7 frequently used in such studies, here we have employed retroviral vectors over-expressing CDK4 or CDK6 as a more representative model of naturally-occurring mutations targeting the Rb pathway. We show that these can extend ®broblast lifespan by *10 population doublings, ending in a viable senescence-like state which contrasts with the apoptotic end-stage seen with E7. Compared with`normal' senescence, this growth arrest was, in most cases, not accompanied by any further increase in p21
Replicative senescence is thought to be a signi®cant barrier to human tumorigenesis, which in human ®bro-blasts, and many other cell types, can be overcome experimentally by combined loss of function of p53 and Rb`pathways'. To avoid the confounding pleiotropic eects of HPVE7 frequently used in such studies, here we have employed retroviral vectors over-expressing CDK4 or CDK6 as a more representative model of naturally-occurring mutations targeting the Rb pathway. We show that these can extend ®broblast lifespan by *10 population doublings, ending in a viable senescence-like state which contrasts with the apoptotic end-stage seen with E7. Compared with`normal' senescence, this growth arrest was, in most cases, not accompanied by any further increase in p21
Waf1 levels but with up to a 19-fold increase in p16
Ink4a
. Surprisingly however, this could not explain arrest, since expression of mutant CDK4 and/or CDK6, incapable of binding p16
, did not confer any greater lifespan extension than the wild-type CDKs. Subsequent abrogation of p53 function by a second vector, encoding HPVE6, downregulated p21
Waf1 and conferred a second lifespan extension, ending in a crisis-like state, consistent with full escape from senescence. These data: (i) point to a back-up`senescence' mechanism distinct from induction of p21 Waf1 or p16
Introduction
Most human cancers progress to increasing degrees of malignancy through successive selection of sub-clones with greater proliferative potential (Hanahan and Weinberg, 2000) . A major underlying selection pressure driving this clonal evolution is the need to overcome a succession of intrinsic cellular controls which limit proliferative lifespan (Wynford- Thomas, 1997; Reddel, 2000) . The ®rst of these proliferative lifespan barriers (PLBs),`senescence' or`mortality stage 1' (M1) (Wright et al., 1989) , is a state of viable proliferative arrest, reached in human ®broblasts after around 70 population doublings (PD). Senescent cells become enlarged and¯attened and arrest in the G 1 phase of the cell cycle, consistent with loss of cyclin-dependent kinase (CDK) 2-cyclin E activity and persistence of the retinoblastoma-susceptibility (pRb) protein in its hypophosphorylated, growth-inhibitory form . Lack of CDK2 activity is not due to any shortage of cyclin E, but results, at least in part, from increased total expression of the CDK inhibitor (CDKI) p21
Waf1 re-enforced by release of p21 Waf1 from sequestration in CDK4/6 complexes, brought about by increasing levels of a second CDKI, p16
Ink4a (Berube et al., 1998; Bringold and Serrano, 2000) .
Escape from senescence can be conferred by loss of function of the tumour suppressor gene products p53 and pRb. Experimentally, abrogation of both of these simultaneously, by expression of the DNA tumour virus genes Simian-virus 40 (SV40) T or human papillomavirus (HPV) type 16 E6 plus E7, results in the outgrowth of clones which eventually reach a second PLB,`crisis' or mortality stage 2' (M2), which is due to increasing cell death rather than growth arrest (Wright et al., 1989) . The (very rare) spontaneous escape from crisis observed in human cells is associated with activation of telomerase (Counter et al., 1992) or alternative, recombinationbased, mechanisms for telomere stabilization (Dunham et al., 2000) , consistent with cell death being the result of excessive telomere erosion.
Since spontaneous multiple mutations will only very rarely occur concurrently in the same cell, it could be predicted that in naturally-occurring, as opposed to virally-induced tumours, progression to M2 would require a series of individual mutation events each conferring a wave of clonal expansion. In support of this prediction, human diploid ®broblasts (HDF) in which the normal function of p53 has been abrogated by a retroviral vector encoding HPV16 E6 (without E7) escape M1 but subsequently enter a second, senescencelike growth arrest state (which we have termed M int E6) which supervenes after a smaller number of PD than M2 (Bond et al., 1999) . In contrast to the latter, this is a viable growth arrest state associated with a further elevation in p16
Ink4a level above that seen at M1, which may account for the loss of pRb phosphorylation, despite the reduction in p21
Waf1 expression resulting from loss of p53 function.
Conversely, abrogation of pRb function by HPV16 E7, without directly aecting p53, also extends proliferative lifespan in HDF, but in this case the subsequent end-stage (M int E7) resembles a precocious M2 rather than M1 (Bond et al., 1999) . M int E7 is likely to be triggered by ongoing telomere erosion leading to hyperstimulation of the p53 pathway, as evidenced by the increase in nuclear content of both p53 itself, and its downstream target p21
Waf1 , compared to M1 (Bond et al., 1999) . That this triggers cell death rather than growth arrest can be explained by the additional ability of E7 to abrogate p21
Waf1 function (Funk et al., 1997; Jones et al., 1997) .
Due to its multiplicity of targets, E7 is a crude tool for modelling the mutational events which allow escape from PLBs in naturally-occurring tumours, yet probably for technical reasons, more speci®c experimental disruption of the Rb pathway in normal human cells has only rarely been attempted (Hara et al., 1991) . This pathway is however frequently targeted in spontaneous human tumours, either by direct mutation of Rb itself, or more usually by a functionally-equivalent abnormality in the upstream Rb regulators. Examples of the latter include over-expression of the Rb-inactivating kinases CDK4 and CDK6 or their regulatory cyclin, D1, through gene ampli®cation or rearrangement in sarcomas (Kanoe et al., 1998; Pilotti et al., 1998; Wunder et al., 1999) and gliomas (Costello et al., 1997; Reis et al., 2000) or loss of function/expression of the cognate inhibitor, p16 Ink4a through mutation, deletion or promoter methylation (Ruas and Peters, 1998) . Rarely, a mutation of CDK4 (R24C) which renders it insensitive to p16 may play the same role, notably in melanoma (Wolfel et al., 1995) .
The initial aim of this work was to test the eect on HDF proliferative lifespan of disrupting the Rb pathway using genetic abnormalities which were more directly representative of those found in vivo. Given the anticipated diculty of abrogating p16 expression by an anti-sense approach in a normal human cell type, we chose instead to study the response to upregulation of CDK activity through the forced over-expression of CDK4 or CDK6, either in their wild-type (wt) form or using their arginine to cysteine mutants (R24C and R31C respectively) which are refractory to p16
Ink4a
. We then went on to use this as a basis for modelling clonal evolution in vitro by the sequential disruption of Rb and p53 pathways.
Results

Validation of amphotropic retroviral vectors expressing human CDK4 and CDK6
Early-passage (PDL *35) HDF were infected with retroviral supernatants derived from pBABEpuro vectors encoding wt CDK4, wt CDK6, mutant (R31C) CDK6 (mCDK6), or a pWZLhygro vector encoding mutant (R24C) CDK4 (mCDK4). Western blot analysis of puromycin or hygromycin-selected cultures revealed increases in the corresponding CDK content (compared to pBABEpuro-only controls) of: 14-fold for wtCDK4, 20-fold for wtCDK6 and 11-fold for both mCDK4 and mCDK6 (Figure 1) , con®rming the ecacy of all four vectors.
Extension of lifespan in human diploid fibroblasts overexpressing wtCDK4, mCDK4 (R24C), wtCDK6 and mCDK6 (R31C) Near-senescent HDF (PD 64/65), were infected with the above retroviral vectors, or with those encoding HPV16 E6 or HPV16 E7 for comparison (Bond et al., 1999) . Pooled, drug-selected, populations were used for biochemical analyses; multiple, individual drug-resistant colonies were randomly selected (from clonaldensity seedings) for serial cell counting (by direct microscopic observation).
As expected (Bond et al., 1994 (Bond et al., , 1995 (Bond et al., , 1999 , all 27 control (pBABEpuro) clones ceased proliferation within two weeks of infection ( Figure 2A ) after an average of only three PD ( Figure 2B ) and underwent senescence, as shown by their characteristic morphology ( Figure 3F ), elevated level of SAb-gal (Figure 4) , low (53%) BrdU labelling index (LI) (not shown) and very low apoptotic rate (TdT assay; Figure 4 ). Also as seen previously, colonies expressing HPV16 E6 initially grew rapidly but ceased proliferation after around 8 weeks ( Figure 2A ) at an average size corresponding to 19 PD ( Figure 2B ), and in a state of viable growth arrest ( Figures 3E and Figure 4) closely resembling M1, which we previously designated M int E6 (Bond et al., 1999) . Colonies expressing HPV16 E7 also grew rapidly, before reaching after *4 weeks an M2-like state (Figures 2A, 3G and 4) , previously termed M int E7 (Bond et al., 1999) at an average ®nal colony size corresponding to only *9 PD (although this is undoubtedly an underestimate given the high cell death rate). Forced expression of wtCDK4 generated colonies in which growth was rapid for *4 weeks then began to slow and ®nally ceased after *7 weeks ( Figure 2A ; n=14) corresponding to *13 PD ( Figure 2B ). Colonies expressing mCDK4 diered slightly in that growth started to slow after 2 to 3 weeks (Figure 2A) ; n=16) corresponding to only *9.5 PD ( Figure 2B ).
Taking into account the *3 PD achieved by colonies expressing pBABEpuro alone, the increase in PD beyond normal M1 senescence conferred by vectors expressing wtCDK4, mCDK4, wtCDK6, mCDK6, and E6 can therefore be estimated as *9, *6.5, *9.5, *10 and *16 PD respectively. Surprisingly, the R-to-C mutants of CDK4 and CDK6 appeared to give no additional growth advantage compared to the wt vectors; indeed mCDK4 was less eective.
To investigate a possible additive eect of overexpressing both mutant CDKs, the above experiment was repeated using mCDK4-hygro plus mCDK6-puro vectors, exploiting their dierent selectable markers to obtain dually-infected clones. Similar levels of overexpression of CDK4 and 6 were achieved ( Figure 5 ) to those seen in cells infected with just one mCDK vector. However, the extension of lifespan beyond that of or mCDK6 or control puro-only and multiple individual clones followed over 10 weeks. Data points show mean colony cell counts. Note that a stable end-stage is reached in colonies expressing any of the CDK4 or 6 vectors, similar to that seen with E6 though at a smaller ®nal cell number. In contrast progressive cell loss supervenes in cells expressing E7. (B) Randomly chosen clones from the above experiments were followed up until no further growth occurred. Histogram shows distribution of PD undergone calculated from ®nal colony size assuming no cell loss puro-only controls (calculated, as above, from the ®nal colony size) was 12, 11 and 7 PD for mCDK4+mCDK6, mCDK6-only and mCDK4-only clones respectively, i.e. there was no signi®cant further eect of the combination beyond that obtained with mCDK6 alone.
Phenotypes of M int CDK states
Following our previous nomenclature (Bond et al., 1999) Figure 3E ,F). Cells were large and attened with a granular cytoplasm and could be maintained in a proliferatively quiescent but viable state for prolonged periods of time with occasional refeeding. SAb-gal activity was high (495% of cells positive by histochemical assay), BrdU LI was very low (52%) (data not shown), and TdT assay con®rmed that apoptotic cells in all M int CDK populations were extremely rare ( Figure 4 ). Western blot analysis con®rmed that growth arrest was not due to loss of expression of the exogenous CDK genes ( Figure 5A ,B).
Taken together, these data indicate that the forced over-expression of human CDK4 or 6, either as wt or p16-refractory mutant forms, allows HDF to temporarily escape from normal senescence, generating cell populations that eventually enter a second viable growth arrest state, M int CDK, which resembles M1 and M int E6, rather than M2 and M int E7 in terms of morphology and cell kinetics. Figure 6A ) the latter also being accompanied by strong cytoplasmic as well as nuclear immunostaining ( Figure 4U ).
p53 We previously observed that senescence in HDF is not associated with an increase in cellular content of p53 protein, provided that eects of post-translational modi®cations on antibody binding are excluded (Webley et al., 2000) whereas, in contrast, a marked increase occurs at M int E7 (Bond et al., 1999) . Western blot analysis using an anti-p53 antibody, DO-1, which is not aected by post-translational modi®cation at M1 (Webley et al., 2000) , revealed no change in reactivity at M int wtCDK6 or M int mCDK4 compared to M1 (pBABEpuro) controls, and only a barely detectable increase at M int mCDK6 ( Figure 6B ). However, a *threefold increase was observed at M int wtCDK4 ( Figure 6B ), though as with p21
Waf1 , this was smaller than the elevation at M int E7 (*12-fold).
p16 Ink4a
To take account of the known potential for p16
Ink4a levels to continue to increase with time in (Bond et al., 1999) .
Rb phosphorylation Western blot analysis of Rb protein showed predominance of the hypo-phosphorylated form (pRB in Figure 6D ) in growth-arrested cells at M1 and in the M int CDK states, in contrast to the presence of more slowly-migrating hyper-phosphorylated forms (ppRb) in proliferating early-passage cells.
Changes in cell cycle regulators in early-passage fibroblasts expressing CDK vectors
To determine whether the increase in p16
Ink4a levels in M int CDK cells was related solely to their extended proliferative lifespan as opposed to a direct eect of over-expressed CDKs, early-passage (PD *35) HDF were infected with the CDK vectors and analysed as soon as sucient numbers of drug-selected cells were available. Such`young' HDF cell populations (PD *40) over-expressing either wt or mutant CDK4 or CDK6 all showed a dramatic increase in p16
Ink4a levels, averaging 20 ± 29-fold above the (very low) level in controls expressing pBABEpuro alone ( Figure 7B ). p21
Waf1 was also elevated (12 ± 16-fold), though in contrast to the result with near-senescent HDF, the increase in young cells over-expressing wtCDK4 was no greater than that seen with the other CDK vectors ( Figure 7B ). Likewise, p53 was elevated (12 ± 37-fold) in all CDK over-expressors compared to the pBABEpuro control ( Figure 7A) .
The above results supported the somewhat unexpected possibility that the increased levels of p21 Waf1 and p53 at M int wtCKD4, and of p16 Ink4a at all M int CDK states, compared to M1, might not be due to the increased number of PD undergone. To address this further, a limited time-course analysis was undertaken in which near-senescent HDF (PD *62) infected with the wtCDK4 vector were analysed after either 3 weeks of puromycin selection, while they were still rapidly proliferating, or after reaching their M int CDK state (7 weeks post-selection) and compared in each case with pBABEpuro (senescent) controls matched for total time in culture.
Western blot analysis ( Figure 8B ) showed that p21
Waf1 levels were already markedly elevated at the ®rst time-point and that no further elevation occurred by the time proliferation ceased at M int wtCDK4. Similar results were seen for p53 ( Figure 8A ). In contrast, although p16
Ink4a levels were also elevated at the ®rst time-point compared to age-matched M1 controls, this dierential increased yet further as the cells reached M int wtCDK4 ( Figure 8C ). Overall, therefore these data support a combination of direct and temporally-related mechanisms for p16
Ink4a elevation at M int CDK, but leave open the possibility that elevation in p21
Waf1 and p53 levels may not exceed that initially induced as a direct eect of overexpression of CDK4/6, independent of time or PD.
Sequential expression at M int CDK of HPV16 E6: a model of clonal evolution Our ®nding that forced expression of CDK4 or 6 reproducibly extends proliferative lifespan in HDF provides a plausible selection pressure to explain the occurrence of CDK4 or 6 overexpression in several human tumor types, including sarcomas and gliomas. Since these tumors also frequently exhibit defects in the p53 pathway, we investigated whether the further loss of p53 function in cells approaching M int CDK states would result in yet further extension of lifespan, consistent with a model of clonal evolution based on sequential escape from proliferative lifespan barriers.
HDF which had escaped M1 senescence following expression of wtCDK4, wtCDK6 or mCDK6 puro vectors were infected with a second retroviral vector encoding HPV16 E6 plus neo (or a neo-only control) as they approached their M int CDK states (5 ± 6 weeks post-infection). Cells were selected in puromycin plus G418 at clonal density to permit assessment of interclonal variation and colony yield, or pooled to give mixed populations for growth curve and biochemical analysis.
After 2 weeks of drug selection, all near-M int CDK populations infected with the pBABEneo control vector had generated only very small colonies, averaging *2 PD, which failed to expand further (Figure 9 A,C,E). In contrast, near-M int CDK cells infected with the E6 vector (wtCDK4.E6, wtCDK6.E6 and mCDK6.E6) had produced clones which had undergone an average of 5 to 6 PD and were still expanding. (The colony yield was used to estimate the number of stably-infected cells present in the bulk populations at day 1 of the growth curves in Figure  9G .) WtCDK4.E6 populations continued to grow rapidly for 5 weeks ( Figure 9G ), after which time cell death increased ( Figure 9B ) and no further net growth occurred after 7 ± 8 weeks. mCDK6.E6 populations behaved similarly ( Figure 9F,G) .
Based on maximum colony size attained, and ignoring the confounding eect of cell death, a minimum estimate of the further extension of lifespan conferred by E6 was *11 PD for both wtCDK4 and mCDK6 populations. Growth of wtCDK6.E6 populations, although slower, was more prolonged, resulting in a similar ®nal maximum colony size ( Figure 9G ). In all three cases, the ®nal fate was a crisis-like state of increasing cell death ( Figure 9B,D,F) , from which no spontaneous escape was observed.
Western blot analysis of wtCDK4.E6 and wtCDK6.E6 populations at the point when net growth ®rst ceased showed, as expected from the presence of E6, a reduced level of p53 and p21 WAF1 compared to the corresponding wtCDK.neo controls (Figure 10 ). This was accompanied by a *twofold increase in p16
Ink4a levels ( Figure 10B ).
Discussion
Mechanism(s) of escape from senescence by forced expression of CDK4/6
Our data show ®rstly that replicative senescence in HDF can be temporarily evaded by experimentally increasing the expression of wild-type CDK4 or CDK6. In`normal' senescence (M1), failure to phosphorylate pRb, and consequent arrest in the G 1 phase of the cell cycle, occurs despite the persistence of most of the`positive regulators' of G1/S progression, notably CDK4, 6, cyclin D1, CDK2 and cyclin E. Indeed, complexes of CDK2/E and CDK4/D1 are still present but appear to be catalytically inactive. In the case of CDK2/E this is adequately explained by binding to the CDK inhibitor p21 waf1 (Noda et al., 1994) , the induction of which correlates with, and is necessary for, growth arrest at senescence (Brown et al., 1997) , and is probably mediated by p53 activation consequent upon telomere erosion (Bond et al., 1996) . However, for CDK4 (and 6) the situation is complicated by the additional involvement of a second, senescence-associated CDK inhibitor, p16
Ink4a which inhibits binding of these two kinases to cyclin D1. p16 Ink4a , unlike p21
Waf1 , continues to increase in abundance after senescence has been reached (Alcorta et al., 1996) , but in early M1 a high proportion of CDK4 (and to a lesser extent CDK6) is still free to bind cyclin D1. It has been suggested (Stein et al., 1999) therefore that, at least in this`early M1' phase, p21
Waf1 is necessary for inhibition of these complexes as well as those of CDK2.
Against this background, two complementary mechanisms can be envisaged by which forced expression of CDK4 or 6 might prevent senescence-related growth arrest.
The ®rst of these focuses on the direct role of CDK4 or 6/cyclin D1 complexes in stimulating G1 progression by phosphorylating Rb (Harbour et al., 1999) . Although dicult to assay directly, there is evidence that this kinase activity is absent in normal senescence, presumably through the combined eects of p16 Ink4a in blocking complex formation and of p21 Waf1 in inhibiting any complexes which can still form (Stein et al., 1999) . The introduction of additional CDK4 or 6 should counteract this negative control by acting as à sink' for p16 Ink4a , leaving sucient free CDK for 1, 3) . Western blot analysis of p53 (A), p21 (B) and p16 (C) was carried out after 20 days (lanes 1, 2), at which point the wtCDK4 cells were still rapidly proliferating, and after 50 days (lanes 3, 4) when these cells had reached M int CDK4. Note the increase in the level of p16, but not of p21 or p53, between day 20 and 50 during the period of extended lifespan conferred by wtCDK4
Oncogene Sequential lifespan extension in human fibroblasts M Morris et al binding to cyclin D1. This should have the additional eect of preventing the`redistribution' of cyclin D1 to CDK2 which is seen in senescent cells and which may also contribute to growth arrest, since these complexes are inactive (Morisaki et al., 1999) . The net result will be an increase in CDK4 or 6/cyclinD1 complexes relative to the amount of p21
Waf1 present, resulting in a lower stoichiometry of p21
Waf1 binding, and hence persistence of Rb kinase activity (Cheng et al., 1999; Parry et al., 1999) .
The second mechanism focuses on the indirect role of CDK4 or 6 complexes in sequestering p21
Waf1 away from CDK2/cyclin E . Following on from the above, an additional consequence of increasing the availability of p16-free CDK4 or 6/D1 complexes for binding to p21 waf1 will be to decrease the amount of p21
Waf1 available for inhibiting CDK2/cyclinE. Hence even if over-expression of CDK4 is not sucient to prevent loss of its own Rbkinase activity as cells approach senescence, it can indirectly maintain the activity of CDK2/cyclinE, which may be sucient to allow continued cell proliferation.
Further analysis of the composition and activity of CDK2, 4, and 6 complexes will be necessary to determine the relative importance of the above two mechanisms.
Mechanism(s) of subsequent growth arrest at M int CDK
Fibroblasts which have evaded M1 senescence through exogenous expression of CDK4 or CDK6 subsequently enter a second viable growth arrest state, after *10 PD, which we term here M int CDK. The morphol-G wtCDK4 + E6 wtCDK6 + E6 mCDK6 + E6 Figure 9 Escape from M int CDK following expression of HPV E6. (A ± F) Fibroblasts expressing wtCDK4 (A, B), wtCDK6 (C, D) or mCDK6 (E, F) puro vectors were allowed to grow to within 2 PD of their respective M int states, and were then infected with a second vector encoding HPVE6+neo (B, D, F) or neo-alone (A, C, E). Whereas the neo controls (A, C, E) underwent growth arrest, consistent with M int CDK, all E6 infections yielded colonies which continued to proliferate for several weeks before ending in a crisis-like state characterised by increasing cell death (B, D, F) . G. Growth curves constructed from serial cell counts in the above experiment Figure 10 Western blot analysis of p53, p21
WAF1 and p16
INK4a
in HDF expressing CDK constructs followed by HPV E6. Cultures expressing wtCDK4 plus E6 (lane 4), or wt CDK6 plus E6 (lane 5) were generated as in Figure 9 and analysed by Western blotting using antibodies to p53 (A) or p21 and p16 (B) when they had reached the point of no further net growth. Agematched controls were wtCDK4 plus neo (lane 2), wtCDK6 plus neo (lane 3) and puro plus neo (lane 1). Note the reduction in p21 and p53 levels and the increase in p16 in the cultures expressing E6
Sequential lifespan extension in human fibroblasts M Morris et al ogy of these cells and their very low cell birth and death rates is reminiscent of normal senescence and contrasts sharply with the crisis-like phenotype (M int E7) of increasing death which supervenes in cells which have escaped senescence through expression of HPV E7. In the latter, we had already observed (Bond et al., 1999) a super-induction of both p16
Ink4a and p21
Waf1 , to well above the levels seen at M1, and reasoned that growth arrest failed to occur because both of these inhibitors were blocked by E7 (which abrogates pRB function centrally and also inhibits p21 Waf1 ). We predicted therefore that the more limited upstream' perturbation of the Rb pathway brought about by over-expressing CDK4 or 6 should be compatible with growth arrest in response to either or both of these CDKIs, and this appears to be the case.
Unexpectedly, however, although p16 Ink4a showed a super-induction as at M int E7, this was not seen for p21 Waf1 , which in cells overexpressing three of the four CDK constructs (wt or mCDK6 or mCDK4) was no higher at M int CDK than in normal M1. Given our previous ®nding that the over-expression of p21 at M int E7 was p53-dependent (Bond et al., 1999) , we speculated that this was a consequence of further telomere erosion beyond M1 leading to increased activation of the p53 pathway, and hence predicted that it would also be seen at M int CDK. That this was not observed may be explained on the basis that the extension of lifespan at M int CDK, although similar to M int E7 when calculated from maximum colony size, in fact represents far fewer cell divisions (and hence less telomere erosion) due to the high rate of cell death in cells expressing E7.
Having thereby excluded a direct role for p21 Waf1 in trigerring growth arrest at M int CDK, the obvious remaining candidate is p16 Ink4a , which is consistent with the much higher levels seen in all the M int CDK states compared to M1 and, furthermore, is supported directly by the time course study which showed a progressive increase over the period of extended lifespan.
In cells over-expressing wtCDK4 or 6, the restoration of growth arrest at M int CDK could be explained by a simple scenario, in which p16
Ink4a increases until it reaches a level sucient to bind all the excess CDK, hence eectively restoring the`balance' pertaining at M1. An unexpected ®nding, though, was that the extension of lifespan produced by expression of the mutant forms of CDK4/6 was no greater than that seen with the wild-type. Since these mutants are defective in p16
Ink4a binding, the progressive increase in p16
Ink4a should be much less eective in compensating for the increased CDK level. Indeed, in many of our experiments, the amount of exogenous mutant is many fold higher than the total endogenous pools of CDK4 and 6, so that even if all the latter were to be bound by p16
Ink4a , there should still be sucient free (uninhibitable) mCDK to prevent growth arrest.
One potential explanation was that proliferation in HDF might require a certain minimum level of both CDK4 and CDK6 complexes. If this were the case, over-expression of, for example, mCDK4, while leading to an uncompensatable increase in CDK4/D1 activity, would not prevent the rising p16
Ink4a level from causing growth arrest through inhibition of the endogenous wt CDK6 activity. However, this was not supported by the results of dual infection with both mCDK4 and mCDK6 vectors, which failed to show any signi®cant increase in lifespan extension beyond that seen with a single construct, despite similar levels of expression.
We are therefore forced to the unexpected conclusion that, unless p16 is acting through a target other than CDK4 or 6 (for which there are no known examples), some other mechanism must be responsible for triggering growth arrest at M int CDK. One possibility is a p16
Ink4a surrogate capable of acting equally on mutant and wild-type forms of CDK4/6 but there is no evidence that the other known members of this family could ful®l this role. The most likely explanation at present is a CDKI-independent inhibition of CDK2 activity, for which a strong candidate would be loss of CDC25A expression or activity, and indeed this has recently been shown to play a key role in growth arrest in response to some forms of DNA damage (Mailand et al., 2000) .
Induction of CDK inhibitors by CDK4 or 6 over-expression, independent of proliferative`age'
Since the level of p16 Ink4a is extremely low in young HDF and accumulates at the very end of their proliferative lifespan (Alcorta et al., 1996; Hara et al., 1996; Stein et al., 1999) , it was initially expected that the high levels observed in M int CDK populations were a result purely of their extended proliferative lifespan and that over-expression of the CDKs in young (pre-M1) cells would not in¯uence p16 Ink4a expression. This, however, was not the case. All four CDK4/6 vectors, when stably expressed in earlypassage ®broblasts, induced p16
Ink4a protein to a level comparable to that seen in normal cells at early-M1. This was accompanied by induction of both p21 Waf1 and p53. Despite the increased levels of these CDKIs, these cultures showed no detectable reduction in growth rate (data not shown).
It has already been shown that lack of functional Rb protein can lead to elevated p16
Ink4a levels (Parry et al., 1995) suggesting that Rb negatively regulates p16
Ink4a . There is also good evidence that loss of Rb function can activate the p53 pathway through release of E2F leading to increased expression of p14
Arf and hence inhibition of mdm2-mediated degradation of p53 (Bates et al., 1998; Sherr and Weber, 2000; Tao and Levine, 1999) . The simplest interpretation of the current ®ndings therefore is that overexpression of CDK4/6 is acting to functionally inactivate Rb, resulting in aberrant E2F activity (Bates et al., 1998) , which switches on the Arf-p53-p21 pathway, and possibly also p16
Ink4a (Dimri et al., 2000) . In the latter case, this is likely to be an indirect response since there is no evidence, to date, of E2F binding sites in the p16 promoter (Hara et al., 1996; Li et al., 1994) and in the light of recent data (Ohtani et al., 2001) , it will be of interest to examine the possible role of Id and Ets family members.
In other words, CDK4 and CDK6 are eectively activating a negative-feedback loop whose eect is tò dampen' their impact on cell cycle regulation. Nevertheless, the observation that their overexpression extends proliferative lifespan indicates that, as with most such loops, the feedback does not succeed in totally compensating for the primary stimulus.
Further extension of lifespan beyond M int CDK by abrogation of p53 function
We went on to show that introduction of a second retroviral vector, encoding HPVE6, into cultures which were reaching the end of the initial lifespan extension conferred by CDK4/6, resulted in a second period of extended growth, eventually ending in a crisis-like state.
As expected, expression of E6 down-regulated p53 and greatly reduced the expression of p21
Waf1 , consistent with this being maintained at least in part by activation of p53 (most probably in response to telomere erosion) (Webley et al., 2000) . On the assumption that growth arrest at M int CDK is dependent on (though as discussed above not directly triggered by) the p16-induced redistribution of p21
Waf1 from cyclin D-CDK4/6 to cyclin E-CDK2, then the initial escape from M int CDK can readily be explained by the relative lack of p21
Waf1 in cells expressing E6. That these cells ®nally end up in crisis indicates that, in the continuing presence of very high levels of CDK4/6, even the further elevation of p16 Ink4a which subsequently occurs is insucient to release enough of this depleted total pool of p21
Waf1 to restore growth arrest before telomere erosion becomes lethal. Likewise, our previous observation that ®broblasts expressing E6 alone can achieve a stable arrest (the M int E6 state) (Bond et al., 1999) presumably re¯ects their lower level of CDK4/6 which enables the rising level of p16
Ink4a to make a much greater proportion of the p21
Waf1 pool available for inhibition of CDK2. Our data therefore support conclusions reached from studies of p16/p21 null lines (Mitra et al., 1999) and p21-null HDF (Brown et al., 1997; Wei and Sedivy, 1999) which indicate that p16 requires p21
Waf1 in order to bring about cell-cycle arrest.
Although we did not measure telomere length, it can be assumed from the minimum estimates of PD undergone, that the ®nal fate of the dually-infected colonies is due to cell death triggered by critical loss of telomere function, as observed in cells expressing E7 plus E6, or SV40 T. Escape from this depends on a rare event leading to telomerase activation, or alternative recombination-based mechanisms (Dunham et al., 2000; Wright and Shay, 2000) and was probably not seen here simply because insucient cell numbers were followed up.
There have, of course, been numerous experimental demonstrations of synergy between loss of Rb and p53 function. Nearly all of these however have been in a very dierent context in which the eect of abrogating Rb is to induce immediate growth arrest and/or apoptosis, escape from which necessitated a simultaneous loss of p53 function (Morgenbesser et al., 1994; Pan and Griep, 1994 ). As we have argued previously Wynford-Thomas et al., 1996) , such experiments may be a poor representation of spontaneous tumorigenesis, since they fail to take account of the very low probability that two mutational events will take place concurrently in the same cell. In contrast, in the`sequential' model of Rb/p53 cooperation presented here, perturbation of the Rb pathway has no immediate inhibitory eect and the subsequent loss of p53 function does not become necessary until after a period of clonal expansion potentially sucient to provide a signi®cant chance of this occurring spontaneously in vivo. (Our failure to observe spontaneous escape from M int CDK in vitro is explicable simply by the relatively small number of clones followed up, and by the experimental design which, in contrast to a naturally-occurring situation, constrained the acquisition of the ®rst`event' to cells which were already near M1, hence limiting the size of the resulting clones to 510 4 cells.) Finally, since previous studies of HDF senescence have all manipulated Rb and p53 function simultaneously in pre-senescent cells, this has left open the possibility that clones in which Rb function is initially compromised alone might engage an irreversible lifespan`clock' which could not be overcome by a later loss of p53. Our data formally exclude this possibility and represent, to our knowledge, a unique in vitro model of clonal selection through sequential dysfunction of Rb and p53 pathways in a relevant human cell context.
Materials and methods
Cell culture
Normal human diploid ®broblasts (HDF) (strain HCA2, kindly provided by James Smith, Houston, TX, USA) were grown in Dulbecco's modi®ed Eagle medium (DMEM) (Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum (FCS) (Imperial Labs, London, UK). Determination of in vitro life span and passage protocols were as described previously (Bond et al., 1995) . Senescence, de®ned by previously described criteria (Gire and Wynford-Thomas, 1998) occurred at an estimated population doubling level (PDL) of 66 to 67.
Retroviral vector production and gene transfer
Human wild-type (wt) CDK4, CDK6 and mutant (R31C) CDK6 cDNAs in pBluescript (kindly provided by Gordon Peters, ICRF, London) were re-cloned into the BamHI and EcoRI sites of retroviral vector plasmid pBABEpuro (Morgenstern and Land, 1990). Mutant (R24C) human CDK4 was obtained already cloned into the retroviral vector pWZLhygro (kindly provided by Manuel Serrano, Madrid, Spain) (Serrano et al., 1997) . (Attempts to re-clone this into pBABEpuro were, for unknown reasons, unsuccessful). A retroviral vector expressing HPVE7 was constructed by PCR synthesis of the E7 open reading frame, together with a consensus upstream Kozak sequence, plus the appropriate restriction sites to allow ligation into the BamHI and EcoRI sites of pBABEpuro. For HPVE6 we used, as previously, the pLXSN-E6 vector (Halbert et al., 1991) kindly provided by Denise Galloway (Seattle, Washington, USA), in which the selectable marker is neo, rather than puro, allowing for dual selection in later work.`Empty' pBABEpuro or neo vectors were used as negative controls.
For all except mutant CDK4, retroviral producer cell clones were obtained by stable transfection of the packaging line psi-CRIP followed by drug selection. The optimum clones gave titers, as assessed by transduction of drugresistance to a human cell line (A431), of 10 , and 8610 5 for puro control, E7, E6, wtCDK4, wtCDK6 and mutant CDK6 vectors respectively. Since the psi-CRIP line is already hygromycin resistant, for pWZLhygro-CDK4 (R24C), retroviral supernatants were produced by transient transfection of Phoenix producer cells (Grignani et al., 1998) .
Retroviral gene transfer into ®broblasts was carried out as described previously (Bond et al., 1994) . Two days after infection, cultures were passaged at dilutions of 1/2 to 1/800, and selection in puromycin (2.5 mg/ml), hygromycin (0.4 mg/ ml) or G418 (0.4 mg/ml) was begun the following day.
Detection of SAb-Gal activity
Endogenous senescence-associated mammalian b-galactosidase activity (SAb-Gal) (Dimri et al., 1995) was assessed histochemically (Bond et al., 1999) using X-Gal substrate (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) at acidic pH.
TdT assay
Cytospin preparations of trypsinized cultures were analysed for the presence of apoptotic cells using a terminal deoxynucleotidyl transferase assay (Promega, Southampton, UK), as previously described (Bond et al., 1999) .
p21 WAF1 immunocytochemistry
Cultures were ®xed in 4% paraformaldehyde (10 min), and then pre-treated with 50 mM glycine (10 min), 0.2% Triton X-100 (10 min) and 0.3% H 2 O 2 (3 min), following which non-speci®c binding was blocked with 2% horse serum (10 min). Anti-p21 mouse monoclonal antibody (Clone 6B6; Pharmingen International) was applied for 30 min followed by detection of binding using the mouse-speci®c avidinbiotin-peroxidase (ABC) system (Novocastra, Newcastleupon Tyne, UK).
Immunoblotting
Cells were lysed for 5 min at 48C by 1% NP-40 in 150 mM NaCl-50 mM TrisHCl (pH 8.0)-5 mM EDTA buer, containing 3 mM phenylmethylsulphonyl¯uoride, 0.01 mg/ml aprotinin and 0.01 mg/ml leupeptin. Protein samples (20 mg each) were separated on sodium dodecyl sulphate-12% polyacrylamide electrophoresis gels and electroblotted to Transblot polyvinylidene di¯uoride membrane (Bio-Rad). After blocking non-speci®c binding, mouse monoclonal antibodies to p53 (DO1, clone Ab6; Calbiochem), p21 (6B6), p16 (DCS50, clone Ab1; Calbiochem), CDK4 (clone DCS35), or CDK6 (clone DCS130) were applied for 1 h. (The latter two were kindly provided by Dr Jiri Bartek, Danish Cancer Society, Copenhagen). This was followed by rabbit antimouse Igperoxidase conjugate (Dako) and detection by the enhanced chemiluminescence system (Nycomed Amersham, Little Chalfont, UK). Filters were then stained with India ink and quantitation of the speci®c signal and the amount of protein loaded was performed using a Bio-Rad imaging densitometer running Molecular Analyst software. In most cases, comparisons of dierent cell populations were based on four replicates, data being given as mean+standard error.
Analysis of pRb phosphorylation state
Cells were lysed in the above buer containing in addition 50 mM sodium¯uoride, and 200 mM sodium orthovanadate. Protein samples were separated on a 7% polyacrylamide electrophoresis gel and analysed as above by Western blotting using a mouse monoclonal antibody to pRb (Clone G3-245; Pharmingen).
